Research has found that therapies delivering hydrogen sulfide to cells may lead to new treatments for obesity and related diseases. Hydrogen sulfide plays a crucial role in liver function, impacting how the liver processes fat and the function of mitochondria. A study using the compound AP39 in mice on a high-fat diet showed a 32% decrease in weight gain over 12 weeks and reduced fat accumulation in the liver. The research suggests that targeting mitochondria with hydrogen sulfide could be a promising approach for treating obesity. This study highlights the potential for developing innovative therapies using hydrogen sulfide to address metabolic diseases.
Source link
New research explores hydrogen sulfide as treatment for obesity
